Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00035139 · ClinicalTrials.gov registry record · Phase 4
Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery
A Phase 4 study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- Phase 4
- Development phase
NCT00035139 is a Phase 4 study that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00035139, a Phase 4 study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- Phase 4
- Development phase
Study Summary
Traumatic Brain Injury (TBI) is the leading cause of acquired long term disability among children and young adults. Deficits in attention and memory are common and persist for years after moderate or severe TBI. The similarity between these symptoms and those of children with AD/HD, the efficacy of methylphenidate in the treatment of AD/HD, and the efficacy of methylphenidate in improving recovery of animals with brain injuries, support the need to study methylphenidate effects in children with TBI. This investigation of methylphenidate in children with moderate to severe TBI aims to: (1) Assess the acute effects of 2 different dosages of methylphenidate on attention and reaction time when the medication is administered to children early in recovery; (2) Assess the ability of 8 weeks of methylphenidate to improve the rate of recovery of cognitive, memory, and attentional skills in children with TBI; (3) Identify the frequency of common methylphenidate side effects in children with TBI.
Interventions
- DRUG methylphenidate
Trial Details
| Field | Value |
|---|---|
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00035139
The ClinicalTrials.gov registry entry for NCT00035139 describes a study currently listed as completed, categorized as Phase 4. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which methylphenidate is the first listed.
NCT00035139 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00035139 about?
NCT00035139 is a clinical study titled "Pediatric Traumatic Brain Injury: Methylphenidate Effects on Early Recovery". Traumatic Brain Injury (TBI) is the leading cause of acquired long term disability among children and young adults. Deficits in attention and memory are common and persist for years after moderate or severe TBI. The similarity between these symptoms and those of children with AD/HD, the efficacy of ...
What is the current status of trial NCT00035139?
This trial is currently completed. It is a Phase 4 study.
What interventions are being tested in trial NCT00035139?
The interventions under investigation include: methylphenidate (DRUG).
Who is sponsoring clinical trial NCT00035139?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.